US Stock MarketDetailed Quotes
BPMC Blueprint Medicines
- 92.260
- -0.030-0.03%
Close Apr 24 16:00 ET
- 92.260
- 0.0000.00%
Post 17:11 ET
5.65BMarket Cap-11022P/E (TTM)
93.740High90.430Low588.54KVolume91.780Open92.290Pre Close54.39MTurnover0.97%Turnover RatioLossP/E (Static)61.23MShares101.00052wk High43.25P/B5.59BFloat Cap43.89052wk Low--Dividend TTM60.55MShs Float125.610Historical High--Div YieldTTM3.59%Amplitude13.040Historical Low92.422Avg Price1Lot Size
About Blueprint Medicines Company
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Company Profile
SymbolBPMC
Company NameBlueprint Medicines
Listing DateApr 30, 2015
Issue Price18.00
Founded2008
CEOMs. Kathryn Haviland
MarketNASDAQ
Employees655
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address45 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-374-7580
Company Executives
- Name
- Position
- Salary
- Kathryn Haviland
- Director, President and Chief Executive Officer
- 6.22M
- Christina Rossi
- Chief Operating Officer
- 2.77M
- Michael Landsittel
- Chief Financial Officer
- 2.36M
- Tracey L. McCain, Esq.
- Chief Legal and Compliance Officer
- 2.34M
- Debra Durso-Bumpus
- Chief People Officer
- --
- Dr. Percy H. Carter, M.B.A.,PhD
- Chief Scientific Officer
- --
- Dr. Becker Hewes, M.D.
- Chief Medical Officer
- --
- Dr. Philina Lee, PhD
- Chief Commercial Officer
- --
- Dr. Christopher K. Murray, PhD
- Chief Technical Operations and Quality Officer
- --
- Ariel Hurley
- Senior Vice President, Finance and Principal Accounting Officer
- --
- Jeffrey W. Albers, J.D.
- Chairman of the Board
- 1.59M
- Dr. Fouad Namouni, M.D.
- President, Research and Development
- 2.81M
- Alexis A. Borisy, A.M.
- Director
- 323.52K
- Dr. John Tsai, M.D.
- Director
- --
- Daniella Beckman
- Independent Director
- 326.51K
- Dr. Lynn Seely,M.D.
- Lead Independent Director
- 373.59K
- Dr. Nicholas Lydon, F.R.S.,PhD
- Independent Director
- 348.45K
- Lonnel Coats
- Independent Director
- 346.39K
- Habib J. Dable
- Independent Director
- 473.26K
- Dr. Mark Alan Goldberg, M.D.
- Independent Director
- 336.82K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
